Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (361-370 of 519) with videos related to

Pageof 52
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
European Urology|January 10, 2021
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate CancerIrene Casanova-Salas, Alejandro Athie, Paul C Boutros, et al.
Research Square|April 8, 2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancerLiang Dong, Cong Hu, Zehua Ma, et al.
Medical Oncology (Northwood, London, England)|June 5, 2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancerLiang Dong, Cong Hu, Zehua Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.
The Prostate|November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
Cancer Cell|May 15, 2014
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancyAlvaro Aytes, Antonina Mitrofanova, Celine Lefebvre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyLiang Dong, Yun Su, Yinjie Zhu, et al.
International Journal of Cancer|May 4, 2004
Cellular interactions in the tropism of prostate cancer to boneRobert A Sikes, Brian E Nicholson, Kenneth S Koeneman, et al.
Cancer Research|November 17, 2007
A polycomb repression signature in metastatic prostate cancer predicts cancer outcomeJindan Yu, Jianjun Yu, Daniel R Rhodes, et al.
Pageof 52

Showing results (361-370 of 519) with videos related to

Sort By:
Pageof 52
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
European Urology|January 10, 2021
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate CancerIrene Casanova-Salas, Alejandro Athie, Paul C Boutros, et al.
Research Square|April 8, 2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancerLiang Dong, Cong Hu, Zehua Ma, et al.
Medical Oncology (Northwood, London, England)|June 5, 2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancerLiang Dong, Cong Hu, Zehua Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.
The Prostate|November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
Cancer Cell|May 15, 2014
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancyAlvaro Aytes, Antonina Mitrofanova, Celine Lefebvre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyLiang Dong, Yun Su, Yinjie Zhu, et al.
International Journal of Cancer|May 4, 2004
Cellular interactions in the tropism of prostate cancer to boneRobert A Sikes, Brian E Nicholson, Kenneth S Koeneman, et al.
Cancer Research|November 17, 2007
A polycomb repression signature in metastatic prostate cancer predicts cancer outcomeJindan Yu, Jianjun Yu, Daniel R Rhodes, et al.
Pageof 52